Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

147.94 +0.75 (+0.51%)
Streaming Delayed Price Updated: 12:29 PM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
21 22 Next >
ITC Wants Apple Ban Reinstated, Calls Apple's Arguments 'Weak And Unconvincing'
The U.S. International Trade Commission (ITC) has opposed Apple's plea to put on hold an import ban on certain Apple Watch models. 
Via Benzinga
Apple's Win
We've also got some productivity tips for the new year. 
Via The Motley Fool
Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance
From Masimo Corporation
Via Business Wire
Apple Stock Is Still A Buy. Here’s Why.
Investors should remain bullish on AAPL stock as the company grows its services business and brings new products to market. 
Via InvestorPlace
There's Uncertainty Around Apple's Patent Appeal For Watch, Masimo's Royalty Exposure Is Priced In - Analyst Downgrades
Needham downgraded Masimo Corporation (NASDAQ: MASI), noting that though Apple Inc (NASDAQ: AAPL) royalties are not certain, but are mostly priced into MASI shares. 
Via Benzinga
Topics Intellectual Property
Is the Apple Watch ban the tipping point?
Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the 
Via MarketBeat
Topics Intellectual Property Stocks
Bear Of The Day: Masimo
Masimo (MASI) , a medical device company, has seen significant downward pressure on its earnings estimates over the last two months, downgrading the stock to a Zacks Rank #5 (Strong Sell), and... 
Via Talk Markets
Benzinga Bulls And Bears: Tesla, Apple, Microsoft, Plug Power And Analyst Sees Precursor To Dogecoin Rally
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Apple Is 'Working Desperately' To Overcome Watch Import Ban With Software Redesign, Aiming For January Launch Amid Patent-Infringement Case: Report
Apple is redesigning software for compliance, hoping to gain approval from a U.S. customs agency by Jan.12 to sell compliant device versions. 
Via Benzinga
Joe Biden Vs. Apple Watch: White House Upholds Ban, Masimo CEO One Of President's 'Closest Friends'
The Apple Watch vs. Masimo battle could spill over into politics with the CEO of Masimo a major Democratic donor and friend of Joe Biden. 
Via Benzinga
S&P 500 Inches Higher, Small-Cap Rally Stalls, Bitcoin Sinks: What's Driving Markets Thursday?
Wall Street is navigating another quiet session characterized by low trading volumes in the post-holiday period. The S&P 500 index continues its gradual ascent toward retesting its all-time highs,... 
Via Benzinga
Topics Stocks
Apple’s Market Maneuvers: Is AAPL Stock a Smart Buy at $193?
A ban on the Apple Watch could hit AAPL stock hard as the wearable is the tech stock's second biggest money-maker 
Via InvestorPlace
How A Late-Night Email To Tim Cook 10 Years Ago Possibly Triggered Masimo's Battle To Get Apple Watch Banned
In 2013, a scientist named Marcelo Lamego fired off an email to Cook, pitching a vision that could propel Apple to the forefront of the medical, fitness, and wellness market, Bloomberg reported. 
Via Benzinga
US Stocks Pause, Gold Rises As Dollar, Treasury Yields Fall: What's Driving Markets Wednesday?
The U.S. stock market experienced a quiet day on Wednesday, with major indices showing minimal movement amid typical year-end low volume activity. The S&P 500 hovered around 4,777 points, remaining... 
Via Benzinga
Apple Wins Temporary Reprieve in Watch Import Ban Over Masimo's Pulse Oximetry Patent Row
On Wednesday, a U.S. 
Via Benzinga
Topics Intellectual Property
Apple Pauses Watch Sale Due to Technology Dispute. What Should You Do With the Stock?
Apple must halt its Apple Watch sales before Dec. 25. 
Via The Motley Fool
Apple Appeals Against Smartwatch Sales Ban After White House Declines To Interfere
Apple appeals against a smartwatch sales ban, filing for court review after the White House declines involvement in the U.S. International Trade Commission's imposed restriction due to a patent dispute... 
Via Benzinga
Topics Intellectual Property
Apple's $17B Smartwatch Business At Risk, Cutting-Edge AI Tech 'HUGS' And More: This Week In Appleverse
From threats to its smartwatch operations to a significant increase in its card savings interest rate, let's delve into the Apple-centric news that unfolded this past week. 
Via Benzinga
Topics Artificial Intelligence
Dow Jones Giants Apple, Microsoft Lead Five Stocks Near Buy Points
Investors should keep tabs on these five stocks trading tightly. 
Via Investor's Business Daily
Topics Stocks
'They Haven't Called:' Masimo CEO Awaits Apple's Move In Watch Patent Infringement Dispute
Masimo CEO Joe Kiani has expressed willingness to settle the ongoing patent dispute with Apple related to the Apple Watch Ultra 2 and Apple Watch Series 9, saying that the tech giant has not initiated... 
Via Benzinga
Topics Intellectual Property
Biden Administration 'Tracking' Apple Watch Case — Could White House Veto The Ban?
The Biden administration is closely monitoring a potential ban on Apple Watch sales in the U.S. due to a patent dispute with Masimo Corp, with the U.S. Trade Representative considering whether to lift... 
Via Benzinga
Topics Intellectual Property
Apple Scrambles To Save $17B Smartwatch Business From Impending Ban: Report
Apple is reportedly working to salvage its $17 billion smartwatch business from an impending U.S. ban, set to take effect on Dec. 25, by tweaking algorithms related to blood oxygen level measurement,... 
Via Benzinga
Topics Intellectual Property
Masimo Receives FDA Clearance for Stork™ Baby Monitoring System
From Masimo
Via Business Wire
New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation
From Masimo
Via Business Wire
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
From Masimo
Via Business Wire
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,... 
Via Benzinga
Topics ETFs
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
From Masimo
Via Business Wire
Masimo to Present in Jefferies London Healthcare Conference
From Masimo
Via Business Wire
Wells Fargo Maintains Equal-Weight Rating for Masimo: Here's What You Need To Know
 
Via Benzinga
GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform
From Masimo and GE HealthCare
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.